The first batch of an approved Covid-19 vaccine is expected to arrive in Qatar by the end of this year, a senior health official has reiterated. Dr Hamad Eid al-Romaihi, manager of Health Protection and Communicable Disease Control under the Ministry of Public Health (MoPH)
Just as the novel coronavirus was gaining a foothold in the United States in mid-March, Pfizer Inc Chief Executive Albert Bourla called on his top vaccine scientists and laid out a clear mission:
Moderna Inc's experimental vaccine is 94.5% effective in preventing Covid-19 based on interim data from a late-stage trial, the company said on Monday, becoming the second US drugmaker to report results that far exceed expectations.
The US Centers for Disease Control and Prevention (CDC) said on Wednesday that Covid-19 vaccines may not be initially recommended for children, when they become available.
The US Food and Drug Administration made public its guidance for issuing emergency approval for a Covid-19 vaccine on Tuesday, making it clear it wants to see follow-up two months after trial volunteers have their second dose.
Moderna Inc said on Friday it was on track to produce 20 million doses of its experimental coronavirus vaccine by the end of the year, while maintaining its goal of readying 500 million to 1 billion doses in 2021.
The first two Covid-19 vaccines to enter large-scale US trials will not be tested in pregnant women this year, raising questions about how this vulnerable population will be protected from the coronavirus
Moderna Inc plans to price its experimental coronavirus vaccine in a way that ensures broad access, it said on Wednesday, adding that it did not intend to conduct late-stage trials of the vaccine outside the United States.
Moderna Inc's vaccine against Covid-19 could be rolled out by the end of this year, US officials said on Monday, after the drugmaker announced the start of a 30,000-subject
Moderna Inc said on Sunday it has received an additional $472 million from the US government's Biomedical Advanced Research and Development Authority
Weill Cornell Medicine-Qatar (WCM-Q) has signed a research agreement with pioneering US biotechnology company Moderna, Inc. to develop a new cholesterol-controlling drug